Advertisement
CTVA 外匯新聞
Corteva Sees Q3 Results Below Estimates; Slashes FY23 Outlook
Announcing preliminary net sales and earnings results for the third quarter on Friday, Corteva, Inc. (CTVA) now expects third-quarter loss from continuing operations of $0.45 per share on net sales of approximately $2.6 billion.
RTTNews
|
738天前
Evogene's Lavie Bio Inks Licensing Agreement For Bio-Fungicides With Corteva Agriscience
Lavie Bio Ltd., a subsidiary of ag-biologicals company Evogene Ltd. (EVGN) announced on Monday a licensing agreement with ag innovation company Corteva Inc. (CTVA), that grants Corteva exclusive rights to further develop and commercialize the lead bio-fungicide product candidates targeting fruit rots and powdery mildew, which were discovered and developed by Lavie Bio.
RTTNews
|
840天前
